Translational potential of a novel osteoclast inhibitor, eliglustat, in myeloma bone disease

<p>Multiple myeloma is a fatal haematological malignancy, in which the majority of patients either present with or develop a destructive and debilitating osteolytic bone disease. The bone disease is characterised by an increase in osteoclastogenesis and by osteoblast suppression. Current trea...

Полное описание

Библиографические подробности
Главный автор: Leng, H
Другие авторы: Simon, K
Формат: Диссертация
Язык:English
Опубликовано: 2019
Предметы:

Схожие документы